Company Number: 13821109

Analysis Date: 2025-07-29 15:04 UTC

Financial Health Assessment for KERDISTONE TRADING LIMITED

---

1. Financial Health Score: C

Explanation:
KERDISTONE TRADING LIMITED shows characteristics of a company with a stable but cautious financial position. The company holds significant fixed asset investments but has experienced a notable decline in cash reserves and a small operating loss. While shareholders’ funds remain healthy, the drop in liquid assets and persistent losses suggest some symptoms of financial strain. The score "C" reflects a company that is solvent but requires attention to improve liquidity and operational profitability for a healthier outlook.

---

2. Key Vital Signs

Metric	2023 Value	2022 Value	Interpretation
Cash at Bank	£2,334	£127,717	Sharp decline signals liquidity tightening; "weak pulse" in cash flow.
Net Current Assets	£2,334	£127,717	Working capital has dropped significantly; warning sign for short-term obligations.
Total Assets Less Current Liabilities	£398,329	£438,616	Strong asset base, largely due to investments in partnerships.
Shareholders’ Funds	£398,329	£438,616	Healthy equity position, but decreased by ~9%.
Operating Loss	£(3,191)	£(1,243)	Operating expenses exceed income, indicating negative operational "vital signs."
Fair Value Adjustment on Investments	£(37,275)	£2,440	Investment value decreased, reflecting market or asset-specific "stress."
Share Capital	£218,750	£218,750	Stable capital base, indicating no recent equity dilution.

---

3. Diagnosis

KERDISTONE TRADING LIMITED exhibits a stable but fragile financial condition. The company’s balance sheet is anchored by significant fixed asset investments in partnerships, which represent the bulk of its asset value. However, these investments have experienced a fair value decline (£37,275 loss), indicating some market or operational challenges affecting investment performance.

The cash position—a critical "heartbeat" for day-to-day operations—has weakened drastically from £127,717 to £2,334 within one year. This suggests that while the company still has solid net assets, it may face difficulties meeting short-term obligations or funding operational needs without additional cash inflows or financing.

Operating loss worsened from £1,243 to £3,191, highlighting ongoing operational inefficiencies or lack of revenue generation. The company recorded no turnover in both periods, indicating it may be holding investments without active trading or income from core operations.

The net current assets dropped similarly, signalling a reduction in working capital "reserves." This could constrain the ability to respond to unexpected expenses or seize growth opportunities.

The equity base remains strong, backed by share capital and share premium, but the decline in retained earnings and the revaluation reserve turning negative reflects accumulated losses and asset depreciation.

Overall, the "symptoms" suggest the company is solvent but under financial stress primarily due to liquidity constraints and operational losses. The company is not in immediate danger but requires intervention to restore a healthy cash flow and improve operational efficiency.

---

4. Recommendations

1. Improve Cash Flow Management:

   • Prioritize activities to generate cash or secure short-term financing to rebuild liquid reserves.
   • Consider delaying non-essential expenditures or capital calls on investments until cash flow improves.

2. Review Investment Portfolio:

   • Conduct a detailed assessment of partnership interests causing fair value losses.
   • Explore opportunities to divest underperforming investments to release cash and reduce asset "stress."

3. Operational Strategy Review:

   • Develop or revive revenue-generating activities to offset administrative expenses.
   • Evaluate cost controls to reduce operating losses and improve profit margins.

4. Enhance Financial Monitoring:

   • Implement regular liquidity and working capital monitoring to detect early signs of financial distress.
   • Prepare cash flow forecasts to manage upcoming obligations and investment needs proactively.

5. Consider Capital Injection or Financing:

   • If operational turnaround requires investment, explore equity funding or debt facilities with manageable servicing costs to support liquidity.

---

Medical Analogy Summary

KERDISTONE TRADING LIMITED is like a patient with a strong skeleton (solid asset base and equity) but weakened circulation (cash flow) and signs of operational fatigue (losses). Immediate focus on restoring the "circulatory system" (cash and working capital) and diagnosing the root cause of operational losses will be key to preventing further decline and ensuring sustainable recovery.

---